Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Mechanism of alternative complement pathway dysregulation by a phosphorothioate oligonucleotide in monkey and human serum.

Henry SP, Jagels MA, Hugli TE, Manalili S, Geary RS, Giclas PC, Levin AA.

Nucleic Acid Ther. 2014 Oct;24(5):326-35. doi: 10.1089/nat.2014.0491. Epub 2014 Aug 5.

PMID:
25093529
2.

Dietary aspartyl-phenylalanine-1-methyl ester delays osteoarthritis and prevents associated bone loss in STR/ORT mice.

Manion CV, Hochgeschwender U, Edmundson AB, Hugli TE, Gabaglia CR.

Rheumatology (Oxford). 2011 Jul;50(7):1244-9. doi: 10.1093/rheumatology/ker089. Epub 2011 Mar 3.

3.

Pancreatic enzymes generate cytotoxic mediators in the intestine.

Penn AH, Hugli TE, Schmid-Schönbein GW.

Shock. 2007 Mar;27(3):296-304.

PMID:
17304111
4.

Intraluminal pancreatic serine protease activity, mucosal permeability, and shock: a review.

Acosta JA, Hoyt DB, Schmid-Schönbein GW, Hugli TE, Anjaria DJ, Frankel DA, Coimbra R.

Shock. 2006 Jul;26(1):3-9. Review.

PMID:
16783190
5.

New standards for manuscripts on natural products.

Talmadge JE, Hugli TE, Fuminori A.

Int Immunopharmacol. 2006 Aug;6(8):1223. Epub 2006 Apr 19. No abstract available.

PMID:
16782533
6.

Editorial.

Talmadge JE, Hugli TE, Fuminori A.

Int Immunopharmacol. 2006 Jul;6(7):1039. Epub 2006 Apr 19. No abstract available.

PMID:
16714206
7.

Contribution of anaphylatoxins to allergic inflammation in human lungs.

Abe M, Hama H, Shirakusa T, Iwasaki A, Ono N, Kimura N, Hugli TE, Okada N, Katsuragi T, Okada H.

Microbiol Immunol. 2005;49(11):981-6.

8.

A new hypothesis for microvascular inflammation in shock and multiorgan failure: self-digestion by pancreatic enzymes.

Schmid-Schönbein GW, Hugli TE.

Microcirculation. 2005 Jan-Feb;12(1):71-82. Review.

PMID:
15804975
9.

Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.

Doucet JJ, Hoyt DB, Coimbra R, Schmid-Schönbein GW, Junger WG, Paul L W, Loomis WH, Hugli TE.

J Trauma. 2004 Mar;56(3):501-10; discussion 510-1.

PMID:
15128119
10.

Characterization of two classes of pancreatic shock factors: functional differences exhibited by hydrophilic and hydrophobic shock factors.

Kramp WJ, Waldo S, Schmid-Schönbein GW, Hoyt D, Coimbra R, Hugli TE.

Shock. 2003 Oct;20(4):356-62.

PMID:
14501950
11.

Elevated kallikrein activity in plasma from stable liver transplant recipients.

Hayashi J, Salomon DR, Hugli TE.

Int Immunopharmacol. 2002 Nov;2(12):1667-80.

PMID:
12469941
12.

Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.

Furuya K, Takeda H, Azhar S, McCarron RM, Chen Y, Ruetzler CA, Wolcott KM, DeGraba TJ, Rothlein R, Hugli TE, del Zoppo GJ, Hallenbeck JM.

Stroke. 2001 Nov;32(11):2665-74.

PMID:
11692032
13.

Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock.

Schmid-Schönbein GW, Kistler EB, Hugli TE.

Biorheology. 2001;38(2-3):185-201.

PMID:
11381174
14.

Pancreatic enzymes and microvascular cell activation in multiorgan failure.

Schmid-Schönbein GW, Hugli TE, Kistler EB, Sofianos A, Mitsuoka H.

Microcirculation. 2001 Feb;8(1):5-14. Review.

PMID:
11296853
15.

Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes.

Kodani M, Sakata N, Takano Y, Kamiya H, Katsuragi T, Hugli TE, Abe M.

Immunopharmacology. 2000 Sep;49(3):263-74.

PMID:
10996024
16.

Respiratory immunology

Hugli TE.

Immunopharmacology. 2000 Jul 25;48(3):213. No abstract available.

PMID:
10960658
17.

Plasma activation during splanchnic arterial occlusion shock.

Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW.

Shock. 2000 Jul;14(1):30-4.

PMID:
10909890
18.

Introduction

Hugli TE.

Immunopharmacology. 2000 Aug;49(1-2):101-2. No abstract available.

PMID:
10904109
19.

Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment.

Tsuji RF, Kawikova I, Ramabhadran R, Akahira-Azuma M, Taub D, Hugli TE, Gerard C, Askenase PW.

J Immunol. 2000 Aug 1;165(3):1588-98.

20.

The pancreas as a source of cardiovascular cell activating factors.

Kistler EB, Hugli TE, Schmid-Schönbein GW.

Microcirculation. 2000 Jun;7(3):183-92.

PMID:
10901497
21.

Mixed effects of TGF-beta on human airway epithelial-cell chemokine responses.

Jagels MA, Hugli TE.

Immunopharmacology. 2000 Jun;48(1):17-26.

PMID:
10822085
23.

Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study.

Pfeifer PH, Brems JJ, Brunson M, Hugli TE.

Immunopharmacology. 2000 Feb;46(2):163-74.

PMID:
10647874
24.

Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Sun J, Ember JA, Chao TH, Fukuoka Y, Ye RD, Hugli TE.

Protein Sci. 1999 Nov;8(11):2304-11.

25.

Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity.

Fukuoka Y, Ember JA, Hugli TE.

Biochem Biophys Res Commun. 1999 Sep 24;263(2):357-60.

PMID:
10491297
26.

Chemotactic mediator requirements in lung injury following skin burns in rats.

Piccolo MT, Wang Y, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO.

Exp Mol Pathol. 1999 Aug;66(3):220-6.

PMID:
10486240
27.

Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses.

Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD.

J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):559-64.

PMID:
10482828
28.
29.

Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells.

Jagels MA, Daffern PJ, Zuraw BL, Hugli TE.

Am J Respir Cell Mol Biol. 1999 Sep;21(3):418-27.

PMID:
10460760
30.

Role of chemotactic factors in neutrophil activation after thermal injury in rats.

Piccolo MT, Wang Y, Verbrugge S, Warner RL, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO.

Inflammation. 1999 Aug;23(4):371-85.

31.
32.
33.

Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.

Chao TH, Ember JA, Wang M, Bayon Y, Hugli TE, Ye RD.

J Biol Chem. 1999 Apr 2;274(14):9721-8.

34.
36.

Complement activation and cytokine generation after modified Fontan procedure.

Mainwaring RD, Lamberti JJ, Hugli TE.

Ann Thorac Surg. 1998 Jun;65(6):1715-20.

PMID:
9647087
37.

A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils.

Nakashima K, Sakurada T, Imayama S, Masukawa S, Ember JA, Hugli TE, Abe M.

Allergy. 1998 Mar;53(3):320-3.

PMID:
9542615
38.
39.

Processing of C5a by human polymorphonuclear leukocytes.

Hetland G, Pfeifer PH, Hugli TE.

J Leukoc Biol. 1998 Apr;63(4):456-62.

PMID:
9544575
40.

Evidence that the receptor for C4a is distinct from the C3a receptor.

Ames RS, Tornetta MA, Foley JJ, Hugli TE, Sarau HM.

Immunopharmacology. 1997 Dec;38(1-2):87-92.

PMID:
9476119
41.

Complement factors and their receptors.

Ember JA, Hugli TE.

Immunopharmacology. 1997 Dec;38(1-2):3-15. Review.

PMID:
9476110
43.

Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.

Fukuoka Y, Ember JA, Hugli TE.

Biochem Biophys Res Commun. 1998 Jan 26;242(3):663-8.

PMID:
9464274
44.
45.

Requirement for C5a in lung vascular injury following thermal trauma to rat skin.

Schmid E, Piccolo MT, Friedl HP, Warner RL, Mulligan MS, Hugli TE, Till GO, Ward PA.

Shock. 1997 Aug;8(2):119-24.

PMID:
9261902
46.

Neutrophil chemotactic activity and C5a following systemic activation of complement in rats.

Schmid E, Warner RL, Crouch LD, Friedl HP, Till GO, Hugli TE, Ward PA.

Inflammation. 1997 Jun;21(3):325-33.

47.

Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard.

Tanaka F, Dannenberg AM Jr, Higuchi K, Nakamura M, Pula PJ, Hugli TE, Discipio RG, Kreutzer DL.

Inflammation. 1997 Apr;21(2):251-67.

PMID:
9187966
48.

C5a-dependent up-regulation in vivo of lung vascular P-selectin.

Mulligan MS, Schmid E, Till GO, Hugli TE, Friedl HP, Roth RA, Ward PA.

J Immunol. 1997 Feb 15;158(4):1857-61.

PMID:
9029126
49.

Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene.

Hsu MH, Ember JA, Wang M, Prossnitz ER, Hugli TE, Ye RD.

Immunogenetics. 1997;47(1):64-72.

PMID:
9382922
50.

cDNA cloning and characterization of rat C5a anaphylatoxin receptor.

Akatsu H, Miwa T, Sakurada C, Fukuoka Y, Ember JA, Yamamoto T, Hugli TE, Okada H.

Microbiol Immunol. 1997;41(7):575-80.

Supplemental Content

Loading ...
Support Center